scholarly article | Q13442814 |
P2093 | author name string | Dennis W Dickson | |
Benoit I Giasson | |||
Stefan Prokop | |||
Anthony T Yachnis | |||
Zachary A Sorrentino | |||
Cara J Riffe | |||
Jorge A Trejo-Lopez | |||
P2860 | cites work | Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling | Q24308725 |
Second consensus statement on the diagnosis of multiple system atrophy | Q24650965 | ||
The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy | Q28085165 | ||
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model | Q28115206 | ||
Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies | Q28205799 | ||
Protein aggregation and neurodegenerative disease | Q28273600 | ||
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment | Q29547294 | ||
Autophagy gone awry in neurodegenerative diseases | Q29614849 | ||
Evaluation of alpha-synuclein immunohistochemical methods used by invited experts | Q30488694 | ||
Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. | Q30585365 | ||
Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity | Q33735667 | ||
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium | Q33869820 | ||
Mallory bodies revisited | Q33899979 | ||
Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein | Q34091623 | ||
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry | Q34556945 | ||
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease | Q34635272 | ||
The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis | Q34768397 | ||
Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy | Q35580643 | ||
Diffuse plaques do not accentuate synapse loss in Alzheimer's disease | Q35812116 | ||
KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. | Q35990138 | ||
Signaling, polyubiquitination, trafficking, and inclusions: sequestosome 1/p62's role in neurodegenerative disease. | Q36626380 | ||
Signal integration and diversification through the p62 scaffold protein | Q36686435 | ||
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. | Q36790701 | ||
Thinking laterally about neurodegenerative proteinopathies | Q36793466 | ||
Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice | Q36907399 | ||
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy | Q36932383 | ||
The neuritic plaque facilitates pathological conversion of tau in an Alzheimer's disease mouse model | Q37063351 | ||
Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. | Q37485777 | ||
p62/SQSTM1/A170: physiology and pathology | Q38030264 | ||
Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. | Q38084406 | ||
The neuropathology associated with repeat expansions in the C9ORF72 gene | Q38172839 | ||
New Perspectives on the Neuropathology in Huntington's Disease in the Human Brain and its Relation to Symptom Variation | Q38234070 | ||
Interactions of pathological proteins in neurodegenerative diseases | Q39236779 | ||
Relationship between plaques, tangles, and dystrophic processes in Alzheimer's disease | Q40416719 | ||
Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau. | Q41196178 | ||
Autophagy-deficient mice develop multiple liver tumors | Q42099409 | ||
p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases | Q42184099 | ||
Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. | Q42491649 | ||
Neuropathological classification of Huntington's disease | Q45297167 | ||
p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. | Q45967668 | ||
Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. | Q47300849 | ||
Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62 | Q48319617 | ||
Brain injection of α-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker. | Q48550878 | ||
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein | Q48581887 | ||
Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation. | Q53352974 | ||
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. | Q54613756 | ||
Activation of p62/SQSTM1-Keap1-Nuclear Factor Erythroid 2-Related Factor 2 Pathway in Cancer. | Q55392669 | ||
Physiological carboxy-truncation of α-synuclein potentiates the prion-like formation of pathological inclusions | Q57458019 | ||
p62 mutations, ubiquitin recognition and Paget's disease of bone | Q58096580 | ||
p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS | Q58477808 | ||
Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases. | Q61718173 | ||
The ubiquitin-binding protein p62 identifies argyrophilic grain pathology with greater sensitivity than conventional silver stains | Q79405792 | ||
Use of p62/SQSTM1 antibodies for neuropathological diagnosis | Q81500829 | ||
Fragile X-associated tremor ataxia syndrome with co-occurrent progressive supranuclear palsy-like neuropathology | Q91005182 | ||
Astrocytic degeneration in chronic traumatic encephalopathy | Q91337171 | ||
Repeat-associated non-AUG (RAN) translation: insights from pathology | Q92659224 | ||
P433 | issue | 4 | |
P304 | page(s) | 407-418 | |
P577 | publication date | 2020-04-01 | |
P1433 | published in | Journal of Neuropathology & Experimental Neurology | Q15716771 |
P1476 | title | Generation and Characterization of Novel Monoclonal Antibodies Targeting p62/sequestosome-1 Across Human Neurodegenerative Diseases | |
P478 | volume | 79 |
Search more.